Can Gap Escape the Whirlwind? New CEO Confronts Years of Decline
Sonia Syngal must defy the vortex consuming companies that weren't prepared for the Covid crisis. She is plotting a future of fewer stores and more fashion risks to revive the company's namesake brand.
Hasbro Posts Rise in 3Q Profit
Hasbro logged a third-quarter profit of $220 million, or $1.61 a share, but revenue from the company's operations that rely on live events suffered during coronavirus pandemic.
Dunkin' Brands in Talks to Be Acquired by Arby's Parent
The parent of Dunkin' and Baskin-Robbins said it has held early talks to go private in an acquisition by Inspire Brands, whose portfolio includes Arby's, Buffalo Wild Wings and Jimmy John's chains.
Oxford, AstraZeneca Vaccine Shows Promising Immune Response in Older Adults
A Covid-19 vaccine being developed by the University of Oxford and AstraZeneca showed a promising immune response and low levels of adverse reactions in the elderly and older adults, according to an interim analysis.
SAP Profit Warning Sends Shares Plummeting
Shares in Europe's biggest tech company plunged after it scrapped its profit targets for the year and said measures to thwart a rebound in coronavirus infections would weigh on business through the middle of next year.
Ant to Raise More Than $34 Billion in Record IPO
In what is due to be the world's biggest-ever initial public offering, Ant Group will be one of the most valuable companies in either technology or finance.
Facebook Moves Into Cloud Gaming
The social-media company's free-to-play model differs from the paid, subscription cloud-gaming services of rivals such as Google and Microsoft.
Auto Makers Shift Hydrogen Focus to Big Rigs
Auto makers have spent decades developing hydrogen fuel cells as a green alternative for cars with little to show for it. Now, they are shifting their attention to the trucking industry.
Bayer to Buy Gene-Therapy Firm AskBio for Up to $4 Billion
Bayer intends to acquire U.S.-based Asklepios BioPharmaceutical to strengthen the German company's drugmaking arm, as Bayer continues to reel from its acquisition of crops giant Monsanto.
Coca-Cola Backs Away From Bottling in Australia as Deal Bubbles to Sell Stake
Coca-Cola agreed in principle to sell its stake in its Australian bottler to one of its European affiliates, its latest move to reduce exposure to costly bottling operations and focus on the more lucrative concentrate-making business.
(END) Dow Jones Newswires